Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 25;14:1069–1084. doi: 10.2147/JIR.S296597

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Downregulation of FUT7 inhibited the proliferation, migration, invasion and EMT of bladder cancer cells. (A and F) CCK8 assay of cell proliferation rate after FUT7 siRNA transfection. (B and G) Colony formation assay of cell proliferation ability after transfection with FUT7 siRNA. (C and H) Transwell assay of cell migration ability after treated with FUT7 siRNA. (D and I) Transwell assay of cell invasion capability after FUT7 siRNA transfection. (E and J) Western blot analysis of the expression changes of EMT-related markers after FUT7 siRNA transfection. The statistical analysis was shown. *P<0.05, **P<0.01, ***P<0.001.